216 related articles for article (PubMed ID: 26634940)
1. Indirect Comparisons and Network Meta-Analyses.
Kiefer C; Sturtz S; Bender R
Dtsch Arztebl Int; 2015 Nov; 112(47):803-8. PubMed ID: 26634940
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
5. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses.
Song F; Altman DG; Glenny AM; Deeks JJ
BMJ; 2003 Mar; 326(7387):472. PubMed ID: 12609941
[TBL] [Abstract][Full Text] [Related]
6. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
7. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
8. Indirect comparisons of competing interventions.
Glenny AM; Altman DG; Song F; Sakarovitch C; Deeks JJ; D'Amico R; Bradburn M; Eastwood AJ;
Health Technol Assess; 2005 Jul; 9(26):1-134, iii-iv. PubMed ID: 16014203
[TBL] [Abstract][Full Text] [Related]
9. Indirect comparisons of therapeutic interventions.
Schöttker B; Lühmann D; Boulkhemair D; Raspe H
GMS Health Technol Assess; 2009 Jul; 5():Doc09. PubMed ID: 21289896
[TBL] [Abstract][Full Text] [Related]
10. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
Jansen JP; Fleurence R; Devine B; Itzler R; Barrett A; Hawkins N; Lee K; Boersma C; Annemans L; Cappelleri JC
Value Health; 2011 Jun; 14(4):417-28. PubMed ID: 21669366
[TBL] [Abstract][Full Text] [Related]
11. Borrowing of strength from indirect evidence in 40 network meta-analyses.
Lin L; Xing A; Kofler MJ; Murad MH
J Clin Epidemiol; 2019 Feb; 106():41-49. PubMed ID: 30342086
[TBL] [Abstract][Full Text] [Related]
12. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
[TBL] [Abstract][Full Text] [Related]
13. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
[TBL] [Abstract][Full Text] [Related]
14. Indirect comparisons: a review of reporting and methodological quality.
Donegan S; Williamson P; Gamble C; Tudur-Smith C
PLoS One; 2010 Nov; 5(11):e11054. PubMed ID: 21085712
[TBL] [Abstract][Full Text] [Related]
15. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
Hoaglin DC; Hawkins N; Jansen JP; Scott DA; Itzler R; Cappelleri JC; Boersma C; Thompson D; Larholt KM; Diaz M; Barrett A
Value Health; 2011 Jun; 14(4):429-37. PubMed ID: 21669367
[TBL] [Abstract][Full Text] [Related]
16. Analysis of adaptive platform trials using a network approach.
Marschner IC; Schou IM
Clin Trials; 2022 Oct; 19(5):479-489. PubMed ID: 35993542
[TBL] [Abstract][Full Text] [Related]
17. Using structural equation modeling for network meta-analysis.
Tu YK; Wu YC
BMC Med Res Methodol; 2017 Jul; 17(1):104. PubMed ID: 28709406
[TBL] [Abstract][Full Text] [Related]
18. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Guelimi R; Garcia-Doval I; Hua C; Hughes C; Naldi L; Kinberger M; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011535. PubMed ID: 37436070
[TBL] [Abstract][Full Text] [Related]
19. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2022 May; 5(5):CD011535. PubMed ID: 35603936
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
